Neurological correlates of fetal cocaine exposure

Annals of the New York Academy of Sciences

Volumn 846, Issue , 1998, Pages 109-125

  Chiriboga, Claudia A ^a,b  

^a Harlem Hospital Center ^*  (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; ILLICIT DRUG;

AROUSAL; ATTENTION DEFICIT DISORDER; CEPHALOMETRY; CONFERENCE PAPER; DOSE RESPONSE; FETUS GROWTH; HUMAN; INTRAUTERINE GROWTH RETARDATION; IRRITABILITY; LOW BIRTH WEIGHT; METHODOLOGY; MUSCLE HYPERTONIA; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGY; NEUROPHYSIOLOGY; PLACENTAL TRANSFER; PRENATAL EXPOSURE; SEIZURE; STROKE;

EID: 0031928820     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09730.x     Document Type: Conference Paper

References (105)

1. O'MALLEY, P.M., L.D. JOHNSTON & J.G. BACHMAN. 1991. Quantitative and qualitative changes in cocaine use among American high school senior, college students and young adults. NIDA Res. Monogr. 110: 19-43.
2. JOHANSON, C.E. & M.W. FISCIIMAN. 1989. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41: 3-52.
3. KURTH, C.P., C. MONITTO, M.L. ALBUQUERQUE, P. FEUER, E. ANDAY & L. SHAW. 1993. Cocaine and its metabolites constrict cerebral arterioles in newborn pigs. J. Pharmacol. Exp. Ther. 265: 587-591.
4. KONKOL, R.J., B.A. ERICKSON, J.K.. DOERR, R.G. HUFFMAN & J.A. MADDEN. 1992. Scizures induced by cocaine metabolite benzoylecgonine in rats. Epilepsia 33: 420-427.
5. SCHENKER, S., Y. YANG, R.F. JOHNSON et al. 1993. The transfer of cocaine and its metabolites across the term human placenta. Clin. Pharmacol. Ther. 53: 329-339.
6. WOODS, J.R., M.S. PLESSINGER & K.E. CLARK. 1987. Effects of cocaine on uterine blood flow. JAMA 257: 957-961.
7. BRUST, J.C.M. 1993. Cocaine. In Neurological Aspects of Substance Abuse. (J.C.M. Brust, Ed.: 82-114. Butterworth-Heinemann. Boston.
8. WOOLVERTON, W.L. & K.M. JOHNSON. 1992. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13: 193-200.
9. DACKIS, C.A. & M.S. GOLD. 1985. New concepts in cocaine addiction: The dopamine depletion hypothesis. Neurosci. Biobehav. Rev. 9: 469-477.
10. FISCHMAN, M.W. 1984. The behavioral pharmacology of cocaine in humans. NIDA Res. Monogr. 50: 72-91.
11. GOEDERDS, N.B. & J.E. SMITH. 1986. Reinforcing properties of cocaine in the medical prefrontal cortex: Primary action of presynaptic dopaminergic terminals. Pharmacol. Biochem. Behav. 25: 191-199.
12. DENEAU, G.A., T. YANAGITA & M.H. SEEVERS. 1969. Self administration of psychoactive substances by monkeys. Psychopharmacologia 16: 30-48.
13. HAMILTON, H.E., J.M. WALLACE, L.P. SHIMEK, S.C. HARRIS & J.G. CHRISTIENSON. 1977. Cocaine and benzoylecgonine excretion in humans. J. Forensic Med. 22: 697-707.
14. WEISS, R.D. & F.H. GAWIN. 1988. Protracted elimination of cocaine metabolites in long-term high-dose cocaine abuser. Am. J. Med. 85: 879-880.
15. GRAHAM, K., G. KOREN, J. KLEIN, J. SCHNEIDERMAN & M. GREENWALD. 1989. Determination of gestational cocaine exposure by hair analysis. JAMA 262: 3328-3330.
16. OSTREA, E.M.J., M.J. BRADY, P.M. PARKS, D.C. ASENSIO & A. NALUZ. 1989. Drug screening of meconium in infants of drug-dependent mothers: An alternative to urine testing. J. Pediatr. 115: 474-477.
17. CHIRIBOGA, C.A., J.C.M. BRUST, D.A. BATEMAN & W.A. HAUSER. 1997. Dose-response effect of fetal cocaine exposure on newborn neurological function. Ann. Neurol. 42: 492 (Abstr.).
18. VAUOHN, A.J., R.P. CARZOLI, L. SANCHEZ-RAMOS, S. MURPHY, N. KHAN & T. CHIU. 1993. Community wide estimation of illicit drug use in delivering women: Prevalence, demographic and associated risk factors. Obstet. Gynecol. 82: 92-96.
19. BATEMAN, D.A., S.K. NG, C.A. HANSEN & M.C. HEAGARTY. 1993. The effect of intrauterine cocaine exposure in newborns. Am. J. Public Health 83: 190-193.
20. MCCALLA, S., H.L. MINKOFF, J. FELDMAN et al 1991. The biological and social consequences of perinatal cocaine use in an inner city population: Results of an anonymous cross-sectional study. Am. J. Obstet. Gynecol. 164: 625-630.
21. ZUCKERMAN, B., D.A. FRANK, R. HINGSON et al. 1989. Effects of maternal marijuana and cocaine on fetal growth. N. Engl. J. Med. 320: 762-768.
22. OSTREA, E.M., M.J. BRADY, S. CAUSE, A.L. RAYMUNDO & M. STEVENS. 1992. Drug screening of newborns by meconium analysis: A large scale, prospective, epidemiological study. Pediatrics 89: 107-113.
23. HABEL, L., K. KAYE & J. LEE. 1990. Trends in the reporting of drug use and infant mortality among drug-exposed infants in New York City. Women Health 16: 41-58.
24. DIGREGORIO, G.J., A.P. FERKO, E.J. BARBIERI et al. 1994. Detection of cocaine usage in pregnant women by urinary EMIT drug screen and GC-MS analyses. J. Anal. Toxicol. 18: 247-250.
25. LINDSAY, M.K., H.B. PETERSON, J. BORING, J. GRAMLING, S. WILLIS & L. KLEIN. 1992. Crack/cocaine as a risk factor for Human Immunodeficiency Virus Infection type I among inner city parturients. Obstet. Gynecol. 80: 981-984.
26. GREENBURG, MSZ, SINGH T, HTOO M. 1991. The association between congenital syphylis and cocaine/crack use in New York City: A case control study. Am J Public Health, 81: 1316-1318.
27. KNIGHT, E.M., H. JAMES, C.H. EDWARDS et al. 1994. Relationship of illicit drug concentrations during pregnancy to maternal nutrition status. J. Nutr. 124: 973S.
28. PICONE, T.A., L.H. ALLEN, P.N. OLSEN & M.E. FERRIS. 1982. Pregnancy outcome in North American women. II. Effects of diet, cigarette smoking, stress and weight gain on placentas, and on neonatal physical and behavioral characteristics. Am. J. Clin. Nutr. 36: 1214-1223.
29. MORO, J.O., B. DE PAREDES, M. WAGNER et al. 1979. Nutritional supplementation and outcome of pregnancy. I Birth weight. Am. J. Clin. Nutr. 32:
30. DRILLIEN, C.M. 1972. Abnormal neurological signs in the first year of life in low-birth weight infants: Possible prognostic significance. Dev. Med. Child. Neurol. 14: 575-584.
31. VILLAR, J., V. SMERIGILIO, R. MARTORELL, C.H. BROWN & R.E. KLEIN. 1984. Heterogeneous growth and mental development of intrauterine growth-related infants during the first 3 years of life. Pediatrics 89: 67-77.
32. CHIRIBOGA, C.A. 1993. Fetal effects. In Neurological Complications of Drug and Alcohol Abuse. J.C.M. Brust Ed.: 707-728.
33. ACKER, D., B.P. SACHS & K.J. TRACY. 1983. Abruptio placentae associated with cocaine use. Am. J. Obstet. Gynecol. 146: 220-221.
34. HADEED, A.J. & S.R. SIEGAL. 1989. Maternal cocaine use during pregnancy: Effects on the newborn infant. Pediatrics 84: 205-210.
35. KAIN, Z.N., L.C. MAYES, C.A. FERRIS, J. PAKES & R. SCHOTTENFELD. 1996. Cocaine-abusing parturients undergoing cesarean section. A cohort study. Anesthesiology 85: 1028-1035.
36. JACOBSON, S.W., J.L. JACOBSON, R.I. SOKOL, S.S. MARTIER & L.M. CHIODO. 1996. New evidence for neurobehavioral effects of in utero cocaine exposure. J. Pediatr. 129: 581-590.
37. CHASNOFF, I.J., D.R. GRIFFITH & S.N. MACUREGOR. 1989. Temporal patterns of cocaine use in pregnancy. JAMA 261: 171-174.
38. TRONICK, E.Z., D.A. FRANK, H. CABRAL, M. MIROCIINICK & B. ZUCKERMAN. 1996. Late dose response effects of prenatal cocaine exposure on newborn neurobehavioral performance. Pediatrics 98: 76-83.
39. CHASNOFF, I.J., W.J. BURNS, S.H. SCHOLL & K.A. BURNS. 1985. Cocaine use in pregnancy. N. Engl. J. Med. 313: 666-669.
40. ORO, A.S. & S.D. DIXON. 1987. Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlates. J. Pediatr. 111: 571-578.
41. BINGOL, N., M. FUCHS, V. DIAZ, R.K. STONE & D.S. GROMISCH. 1987. Teratology of cocaine use. J. Pediatr. 110: 93-96.
42. CHIRIBOGA, C.A., D. BATEMAN, J.C.M. BRUST & W.A. HAUSER. 1993. Neurological findings in cocaine-exposed infants. Fed. Neurol. 9: 115-119.
43. SCAFIDI, F.A., T.M. FIELD, A. WHEEDEN et al. 1996. Cocaine-exposed preterm neonates show behavioral and hormonal differences. Pediatrics 97: 851-855.
44. NAPRIORKOWSKI, B.S., B.M. LESTER, C. FREIER et al. 1996. Effects of in utero substance exposure on infant neurobehavior. Pediatrics 98: 71-75.
45. EISEN, L.N., T.M. FIELD, E.S. BANDSTRA, J.P. ROBERTS, C. MORROW & S.K. LARSON. 1991. Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton Scale. Pediatrics 88: 477-480.
46. NEUSPIEL, D.R., C. HAMEL, E. HOCHBERG, J. GREENE & D. CAMPBELL. 1990. Maternal cocaine use and infant behavior. Neurotoxicol. Teratol. 13: 229-233.
47. CHIRIBOGA, C.A. & D.M. FERRIERO. 1996. Neurological complications of maternal drug abuse. In Principles of Child Neurology, B.O. Berg, Ed.: 1363-1374. McGraw-Hill. New York.
48. KONKOL, R.J., L.J. MURPHEY, D.M. FERRIERO, D.A. DEMSEY & G.D. OLSEN. 1994. Cocaine metabolites in the neonate: Potential for toxicity. J. Child Neurol. 9: 242-248.
49. CHASNOFF, I.J., M.E. BUSSEY, R. SAVICH & C.M. STACK. 1986. Perinatal cerebral infarction and maternal cocaine use. J. Pediatr. 108: 456-457.
50. TENORIO, G.M., M. NAZVI, G.H. BICKERS & R.H. HUBBIRD. 1988. Intrauterine stroke and maternal polydrug use. Clin. Pediatr. (Phila.) 27: 567.
51. DOMINGUEZ, R., A.A. VILA-CORD, J.M. SLOPIS & T.P. BOHAN. 1991. Brain and ocular abnormalities in infants with in-utero exposure to cocaine and other street drugs. AJDC 145: 688-695.
52. BEJAR, R. & S.D. DIXON. 1989. Echoencephalographic findings in neonates associated with maternal and methamphetamine use: Incidence and clinical correlates. J. Pediatr. 115: 770-778.
53. SINGER, L.T., T.S. YAMASHITA, S. HAWKINS, D. CAIRNS, J. BALEY & R. KLIEGMAN. 1994. Incresed incidence of intraventricular hemorrhage and developmental delay in cocaine-exposed infants. J. Pediatr. 124: 765-771.
54. FRANK, D.A. & K. MCCARTEN. 1992. Cranial ultrasounds in term newborns: Failure to replicate excess abnormalities in cocaine-exposed. Ped. Res. 31: 247a.2.
55. DUSICK, A.M., R.F. COVERT, M.D. SCHREIBER et al. 1993. Risk of intracranial hemorrhage and other adverse outcomes after cocaine exposure in a cohort of 323 very low birth weight infants. J. Pediatr. 122: 438-445.
56. DOBERCZAK, T.M., S. SHANZER, R.T. SENIE & S.R. KANDALL. 1988. Neonatal electroencephalographic effect of intrauterine cocaine exposure. J. Pediatr. 113: 354-358.
57. LEGIDO, A., R.R. CLANCY, A.R. SPITZER & L.P. FINNEGAN. 1992. Electroencephalographic and behavioral-state studies in infants of cocaine-addicted mothers. Am. J. Dis. Child. 146: 748-752.
58. KRAMER, L.D., G.E. LOCKE, A. OGUNYEMI & L. NELSON. 1990. Neonatal cocaine-related seizures. J. Child. Neurol. 5: 60-64.
59. CHAVEZ, G.F., J. MULINARE & J.F. CORDERO. 1989. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA 262: 795-798.
60. ANONYMOUS. 1989. Urogenital anomalies in the offspring of women using cocaine during early pregnancy-Atlanta 1968-1980. Morbid. Mortal. Wkly Rep. 38: 536, 541-542.
61. HOYME, H.E., J.K. LYONS & S.D. DIXON. 1990. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 85: 743-747.
62. SHEPARD, T.H., A.G. FANTEL & R.P. KAPUR. 1991. Fetal coronary thrombosis as a cause for single ventricle. Teratology 43: 113-117.
63. HEIER, L.A., C.R. CARPANZO, J. MAST, P.W. BRILL, P. WINCHESTER & M.D. DECK. 1991. Maternal cocaine abuse: The spectrum of radiologie abnormalities in the neonatal CNS. AJNR 12: 951-956.
64. ISENBERG, S., A. SPIERRER & S. INEKELIS. 1987. Ocular signs of cocaine intoxication in neonates. Am. J. Ophthal. 103: 350.
65. GOOD, W.V., D.M. FERRIERO, M. GOLABI & J.A. KOBORI. 1992. Abnormalities of the visual system in infants exposed to cocaine. Ophthalmology 99: 341-346.
66. TESKE, M. & M. TRESE. 1987. Retinopathy of prematurity like fundus and persistent hyperplastic primary vitreous associated with maternal cocaine use. Am. J. Ophthal. 103: 719-720.
67. MAHALIK, M., R. GAUTIERRI & D. MAUN. 1980. Teratogenic potential of cocaine hydrochloride in CF-12 mice. J. Pharmacol. Sci. 111: 703-706.
68. KLEINBAUM, D.G., L.L. KUPPER & H. MORGENSTERN. 1982. Epidemiological Research. Principles and Quantitative Methods. Van Norstrand Reinhold. New York, NY.
69. KANDALL, S.R., J. GAINES, L. HABEL, G. DAVIDSON & D. JESSON. 1993. Relationship of maternal substance abuse to subsequent infant death syndrome in offspring. J. Pediatr. 123: 120-126.
70. DURAND, D.J., A.M. ESPINOZA & B.G. NICKERSON. 1990. Association between prenatal cocaine exposure and sudden infant death syndrome. J. Pediatr. 117: 909-911.
71. DAVIDSON, S.L., D. BAUTISTA, L. CHAN et al. 1990. Sudden infant death syndrome in infants of substance-abusing mothers. J. Pediatr. 17: 876-881.
72. BAUCIINER, H., B. ZUCKERMAN, M. McCLAIN, D. FRANK, L.E. FRIED & H. KAYNE. 1988. Risk of sudden infant death syndrome among infants with in utero cocaine exposure. J. Pediatr. 113: 831-834.
73. SILVESTRI, J.M., J.M. LONG, D.E. WEESE-MAYER & G.A. BARKOV. 1991. Effects of prenatal cocaine on respiration, heart rate and sudden infant death syndrome. Pediatr. Pulmonol. 11: 328-334.
74. GINGRAS, J.L. & D. WEESE-MAYER. 1990. Maternal cocaine addiction. II. An animal model for the study of brainstem mechanisms operative in sudden infant death syndrome. Med. Hypotheses 33: 231-234.
75. SALAMY, A., L. ELDREDGE, J. ANDERSON & D. BULL. 1990. Brainstem transmission time in infants exposed to cocaine in-utero. J. Pediatr. 117: 627-629.
76. SHI, L., B. CONE-WESSON & B. REDDIX. 1988. Effects of maternal cocaine use and the neonatal auditory system. Int. J. Pediatr. Otorrhinlaryngol. 15: 245-251.
77. ANDAY, E.K., M.E. COHEN, N.E. KELLEY & D.S. LEITNER. 1989. Effects of in utero cocaine exposure on startle and its modification. Dev. Pharmacol. 12: 137-145.
78. GRESSENS, P., B. KOSOFSKY & P. EVRARD. 1992. Cocaine-induced disturbances in corticogenesis in the developing murine brain. Neuroscience 140: 113-116.
79. DOW-EDWARDS, D.L. 1989. Long term neurochemical and neurobehavioral consequences of cocaine use during pregnancy. Ann. N.Y. Acad. Sci. 562: 280-289.
80. SPEAR, L.P., L.K. KIRSTEIN & N.A. FRAMBES. 1989. Cocaine effects on the developing central nervous system: Behavioral, psychopharmacological, and neurochemical studies. Ann. N.Y. Acad. Sci. 562: 290-307.
81. FRICK, G.S. & D.L. DOW-EDWARDS. 1994. The effects of cocaine on cerebral metabolic function in periweanling rates: The roles of serotonergic and dopaminergic uptake blockade. Brain Res. 158-170.
82. DOW-EDWARDS, D.L. 1996. Modification of acoustic startle reactivity by cocaine administration during the postnatal period: Comparison with a specific serotonin reuptake inhibitor. Neurotoxicol. Teratol. 18: 289-296.
83. BATTAGLIA, G., T.M. CABRERA & L.D. VAN DE KAR. 1995. Prenatal cocaine exposure produces biochemical and functional changes in brain serotonin systems in rat progeny. NIDA Res. Monogr. 158: 115-148.
84. DAVIS, E., I. FENOY & D. LARAQUE. 1992. Autism and developmental abnormalities in children with perinatal cocaine exposure. J. Natl: Med. Assoc. 84: 315-319.
85. CHASNOFF, I.J., D.R. GRIFFITH, C. FREIER & J. MURRAY. 1992. Cocaine/polydrug use in pregnancy. Pediatrics 89: 284-289.
86. AZUMA, S. & I.J. CHASNOFF. 1993. Outcome of children prenatally exposed to cocaine and other drugs: A path analysis of three year data. Pediatrics 92: 396-402.
87. CHIRIBOGA, C.A., M. VIBBERT, R. MALOUF et al 1995. Neurological correlates of fetal cocaine exposure: Transient hypertonia of infancy and early childhood. Pediatrics 96: 1070-1077.
88. HURT, H., N.L. BRODSKY, L. BETANCOURT, L.E. BRAITMAN, E. MALMUD & J.J. GIANNETTA. 1995. Cocaine-exposed children: Follow-up through 30 months. J. Dev. Behav. Pediatr. 16: 29-35.
89. RICHARDSON G.A., M.L. CONROY & N.L. DAY. 1996. Prenatal cocaine exposure: Effects on the development of school-aged children. Neurotoxicol. Teratol. 18: 627-634.
90. WASSERMAN, G., J. KLINE, D. BATEMAN et al. 1998. Prenatal cocaine exposure and school-age intelligence. Drug Alcohol Dep. In press.
91. CHIRIBOGA, C.A., G.A. WASSERMAN, D.A. BATEMAN et al. 1997. Fetal cocaine exposure and neurological outcome in school-aged children. Unpublished data.
92. BRESLOW, N.E. & N.E. DAY. 1980. The analysis of case control studies. In Statistical Methods in Cancer Research. IARC Scientific publications No. 32. Lyon International Agency for Research in Cancer.
93. WEINBERG, C.R. 1993. Towards a clearer definition of confounding. Am. J. Epidemiol. 137: 1-8.
94. SCHNEIDER, J.W. & I.J. CHASNOFF. 1992. Motor assessment of cocaine/polydrug exposed infants at age 4 months. Neurotoxicol. Teratol. 14: 97-101.
95. FETTERS, L. & E.Z. TRONICK. 1996. Neuromotor development of cocaine-exposed and control infants from birth through 15 months: Poor and poorer performance. Pediatrics 98: 938-943.
96. CHIRIBOGA, C.A., M. VIBBERT, R. MALOUF et al. 1993. Children at risk for HIV infection: Neurological and developmental abnormalities (abstr.) Ann. Neurol. 34: 500-501.
97. LIPTON, S.A. 1997. Neuropathogenesis of acquired immunodeficiency syndrome. Cum Opin. Neurol. 10: 274-253.
98. STRUTHERS, J.M. & R.L. HANSEN. 1992. Visual recognition memory in drugs exposed in infants. J. Dev. Behav. Pediatr. 13: 108-111.
99. MAYES, L.C., M.H. BORNSTEIN, M.A. CHAWARSKA & R.H. GRANGER. 1995. Information processing and developmental assessments in 3-month old infants exposed to cocaine. Pediatrics 95: 539-545.
100. KARMEL, B.Z. & J.M. GARDNER. 1996. Prenatal cocaine exposure effects on arousal modulation attention during the neonatal period. Dev. Psychobiol. 29: 463-480.
101. STANGER, C.M., S. McCONAUGHY & T. ACHENBACH. 1992. Three-year course of a national sample of 4- to 16-year old. II. Predictors of syndromes. J. Am. Acad. Child. Adolesc. Psychiatry 31: 941-950.
102. STRICKLAND, T.L., R. JAMES, H. MYERS, W. LAWSON, X. BEAN & J. MUPPS. 1993. Psychological characteristics related to cocaine use during pregnancy: A postpartum assessment. J. Natl. Med. Assoc. 85: 758-760.
103. ZUCKERMAN, B., H. AMARO, H. BAUCHNER & H. CABRAL. 1989. Depressive symptoms during pregnancy: Relationship to poor health behaviors. Am. J. Obstet. Gynecol. 160: 1107-1111.
104. ZEIDONIS, D.M. & T.R. KOSTEN. 1991. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol. Bull. 27: 337-343.
105. MILLER, H.C. & K. HASSANEIN. 1971. Diagnosis of impaired fetal growth in newborn infants. Pediatrics 48: 511-522.